Wexford Capital’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,000
| Closed | -$779K | – | 248 |
|
|
2025
Q1 | $779K | Buy |
+5,000
| New | +$779K | 0.2% | 91 |
|
|
2020
Q4 | – | Sell |
-5,000
| Closed | -$772K | – | 308 |
|
|
2020
Q3 | $772K | Buy |
+5,000
| New | +$772K | 0.21% | 79 |
|
|
2020
Q2 | – | Sell |
-4,195
| Closed | -$472K | – | 185 |
|
|
2020
Q1 | $472K | Sell |
4,195
-805
| -16% | -$90.6K | 0.17% | 65 |
|
|
2019
Q4 | $696K | Sell |
5,000
-5,000
| -50% | -$696K | 0.11% | 94 |
|
|
2019
Q3 | $963K | Hold |
10,000
| – | – | 0.13% | 79 |
|
|
2019
Q2 | $1.15M | Hold |
10,000
| – | – | 0.13% | 80 |
|
|
2019
Q1 | $1.18M | Hold |
10,000
| – | – | 0.1% | 64 |
|
|
2018
Q4 | $627K | Hold |
10,000
| – | – | 0.05% | 62 |
|
|
2018
Q3 | $709K | Hold |
10,000
| – | – | 0.05% | 111 |
|
|
2018
Q2 | $665K | Buy |
+10,000
| New | +$665K | 0.04% | 99 |
|